These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 37304549)
1. Identification and validation of an epithelial-mesenchymal transition-related lncRNA pairs prognostic model for gastric cancer. Song W; Zhu J; Li C; Peng S; Sun M; Li Y; Sun X Transl Cancer Res; 2023 May; 12(5):1196-1209. PubMed ID: 37304549 [TBL] [Abstract][Full Text] [Related]
2. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients. Wang JM; Li X; Yang P; Geng WB; Wang XY BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810 [TBL] [Abstract][Full Text] [Related]
3. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer. Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J Front Genet; 2021; 12():661306. PubMed ID: 34249086 [TBL] [Abstract][Full Text] [Related]
4. Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer. Shu W; Wang Z; Zhang W; Zhang J; Zhao R; Yu Z; Dong K; Wang H Comb Chem High Throughput Screen; 2023; 26(8):1488-1502. PubMed ID: 36200154 [TBL] [Abstract][Full Text] [Related]
5. Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients. Yuan M; Jia Y; Xing Y; Wang Y; Liu Y; Liu X; Liu D Front Genet; 2022; 13():965033. PubMed ID: 36186426 [No Abstract] [Full Text] [Related]
6. Comprehensive analysis to identify DNA damage response-related lncRNA pairs as a prognostic and therapeutic biomarker in gastric cancer. Yang Y; Zhou L; Gou X; Wu G; Zheng Y; Liu M; Chen Z; Wang Y; Ji R; Guo Q; Zhou Y Math Biosci Eng; 2022 Jan; 19(1):595-611. PubMed ID: 34903003 [TBL] [Abstract][Full Text] [Related]
7. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer. Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844 [TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer. Li D; Lin X; Chen B; Ma Z; Zeng Y; Wang H Front Genet; 2021; 12():723802. PubMed ID: 34659346 [No Abstract] [Full Text] [Related]
9. Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma. Xiao L; Huang Y; Li Q; Wang S; Ma L; Fan Z; Tang Z; Yuan X; Liu B Front Mol Biosci; 2022; 9():976878. PubMed ID: 36060239 [No Abstract] [Full Text] [Related]
10. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer. Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649 [No Abstract] [Full Text] [Related]
11. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. Ma B; Li Y; Ren Y Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579 [TBL] [Abstract][Full Text] [Related]
12. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma. Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203 [TBL] [Abstract][Full Text] [Related]
13. A novel epithelial-mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer. Jin Y; Qiu Y; Li Y; Jiang Z; Hu S; Dai H Medicine (Baltimore); 2023 Jun; 102(26):e34126. PubMed ID: 37390286 [TBL] [Abstract][Full Text] [Related]
14. Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma. Zhou Y; Wang L; Zhang W; Ma J; Zhang Z; Yang M; Yu J; Luo J; Yan Z Dis Markers; 2022; 2022():6335155. PubMed ID: 35111268 [TBL] [Abstract][Full Text] [Related]
15. Identification of an Immune-Related Long Noncoding RNA Pairs Model to Predict Survival and Immune Features in Gastric Cancer. Song S; Liu S; Wei Z; Jin X; Mao D; He Y; Li B; Zhang C Front Cell Dev Biol; 2021; 9():726716. PubMed ID: 34621744 [No Abstract] [Full Text] [Related]
16. A new risk model based on a 11-m Lei L; Li N; Yuan P; Liu D BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776 [TBL] [Abstract][Full Text] [Related]
17. A novel pyroptosis gene expression-based risk score for survival in gastric cancer. Hu J; Song Y; Cai X; Halina H; Qiao K; Lu J; Yin C; Gao F Front Endocrinol (Lausanne); 2023; 14():1120216. PubMed ID: 36793271 [TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma. Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M Front Genet; 2022; 13():794621. PubMed ID: 36313430 [No Abstract] [Full Text] [Related]
19. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer. Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X Front Oncol; 2021; 11():799223. PubMed ID: 35096599 [TBL] [Abstract][Full Text] [Related]
20. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]